Skip to content
healthcare.dev

Amitiza

NDC 64764-080, lubiprostone, capsule, gelatin coated, from Takeda Pharmaceuticals America, Inc..

Product NDC
64764-080
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021908
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64764-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUBIPROSTONE8 ug/1

Pharmacologic classes

Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d474ac6a-444d-4aa6-9986-24be6fcf811d

Use it

Look up 64764-080 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64764-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64764-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.